Ostatní
Návod 
Standard BioTools Inc.
LAB
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.4B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-32%
ROA
-24%
PE
-5
PS
4
Cena 1R
1-2
⌀ Cena
1.27
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
25-02-2026
Poslední dividenda
Profil
Společnost Standard BioTools Inc. vytváří, vyrábí a prodává nástroje, spotřební materiál, činidla a software pro výzkumné pracovníky a klinické laboratoře po celém světě. Nabízí analytické systémy jako Helios, CyTOF systém, Hyperion zobrazovací systémy, Hyperion tkáňové zobrazovače a průtokové vodiče; a testy a činidla, včetně Maxpar činidel, Maxpar přímé imunoprofilovací testy, Maxpar na vyžádání činidla a IMC panelové sestavy pro imunonkologii. Společnost také poskytuje přípravné nástroje, jako jsou systémy Juno, a analytické nástroje zahrnující systém Biomark HD a systém EP1. Kromě toho nabízí integrované fluidní obvody (IFC), jako jsou knihovní příprava IFC, Juno genotypování IFC, dynamické IFC pole, digitální IFC pole a Flex Six IFC; a testy a činidla, včetně Advanta RNA-Seq NGS knihoven přípravných sad, Advanta Dx SARS-CoV-2 RT-PCR testy, Advanta Dx COVID-19 EASE testy, delta gene a SNP testy, přístup k array cílové primery a cílové sekvenování prep primerů a cílené DNA Sep q testy z knihovny. Společnost dále nabízí jednobuněčné mikrofluidické procesy, které zahrnují C1 systémy; přípravné analytické přístroje, které zahrnují C1 IFCs; a softwarová řešení. Své produkty prodává akademickým výzkumným institucím, translačním výzkumným a lékařským centrům, onkologickým centrům, laboratořím klinického výzkumu, biofarmaceutickým, biotechnologickým a rostlinným a živočišným výzkumným společnostem a smluvním výzkumným organizacím. Společnost Standard BioTools Inc. má licenční smlouvy s California Institute of Technology, Harvard University a Caliper Life Sciences, Inc. Společnost byla dříve známá jako Fluidigm Corporation a v dubnu 2022 změnila svůj název na Standard BioTools Inc. Společnost Fluidigm Corporation byla založena v roce 1999 a sídlí v jižním San Francisku v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
814
Založení
2011-02-10
Podobné společnosti
$ 12.09
+ $ 0.12
$ 11.31
+ $ 0.08
$ 4.25
- $ 0.22
$ 3.96
- $ 0.50
$ 16.91
- $ 0.10
$ 4.76
+ $ 0.14
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 85.3 | 85.3 | 174.4 | 106.3 | 97.9 | 130.6 | 138.1 | 117.2 | 113.0 | 101.9 | 104.4 | 114.7 | 116.5 | 71.2 | 52.3 | 42.9 | 33.6 | |
| Cost of Revenues | 42.8 | 42.8 | 90.2 | 55.9 | 60.9 | 61.2 | 54.8 | 53.0 | 51.3 | 50.0 | 46.0 | 46.6 | 42.8 | 20.1 | 15.3 | 13.2 | 11.6 | |
| Gross Profit | 42.5 | 42.5 | 84.3 | 50.5 | 37.1 | 69.4 | 83.3 | 64.3 | 61.6 | 52.0 | 58.4 | 68.1 | 73.6 | 51.1 | 37.0 | 29.7 | 22.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 3.2 | 19.6 | 21.8 | 40.8 | 46.7 | 45.0 | 22.5 | 45.5 | 28.2 | 25.4 | |
| Cost of Revenues | 0.5 | 10.1 | 11.1 | 21.1 | 24.8 | 21.7 | 12.1 | 21.4 | 14.8 | 14.2 | |
| Gross Profit | 2.7 | 9.5 | 10.6 | 19.7 | 21.9 | 23.3 | 10.4 | 24.2 | 13.4 | 11.2 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 25.9 | 38.5 | 37.9 | 36.5 | 31.6 | 30.0 | 30.8 | 38.4 | 39.3 | 43.4 | 19.7 | 16.6 | 13.9 | 13.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 87.5 | 114.8 | 98.9 | 97.9 | 84.5 | 79.8 | 79.5 | 93.2 | 83.0 | 71.3 | 48.1 | 38.5 | 31.3 | 23.5 | |
| Depreciation & Amortization | 11.0 | 1.7 | 16.9 | 15.2 | 2.7 | 23.2 | 16.4 | 17.2 | 16.6 | 18.6 | 17.9 | 16.1 | 4.1 | 2.6 | 1.5 | 1.1 | 1.5 | |
| Total Operating Expenses | 135.8 | 135.8 | 259.5 | 113.5 | 153.3 | 136.8 | 134.4 | 116.1 | 109.8 | 110.3 | 131.6 | 122.2 | 114.7 | 67.8 | 55.1 | 45.2 | 36.6 | |
| Operating Income | -93.3 | -93.3 | -175.2 | -76.6 | -116.2 | -67.5 | -51.0 | -51.8 | -48.2 | -58.4 | -73.2 | -50.2 | -51.8 | -18.0 | -18.1 | -18.6 | -14.6 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.9 | 6.4 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 21.4 | 22.3 | ||
| Depreciation & Amortization | 1.3 | 1.6 | 4.0 | 4.2 | 4.0 | 3.9 | 3.9 | 5.2 | 3.9 | 4.0 | ||
| Total Operating Expenses | 13.9 | 33.0 | 36.3 | 52.7 | 54.7 | 55.0 | 40.6 | 84.4 | 28.3 | 28.7 | ||
| Operating Income | -11.2 | -23.5 | -25.7 | -33.0 | -32.8 | -31.7 | -30.3 | -60.2 | -14.9 | -21.2 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 9.2 | 9.2 | 20.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 3.3 | 4.6 | 4.3 | 3.8 | 3.6 | 4.3 | 13.9 | 5.8 | 5.8 | 5.8 | 5.3 | 0.0 | 0.6 | 3.1 | 2.2 | |
| Other Expense | -3.4 | -3.4 | 36.9 | 2.4 | -76.7 | 3.8 | -3.1 | -14.9 | 0.6 | 0.4 | -1.2 | 5.2 | -11.2 | 1.0 | -0.2 | -3.6 | -0.1 | |
| IBT | -96.7 | -96.7 | -138.3 | -74.2 | -192.9 | -63.7 | -54.1 | -66.7 | -61.4 | -63.8 | -80.2 | -54.8 | -57.7 | -15.7 | -18.9 | -22.3 | -16.8 | |
| Income Tax Expense | -37.9 | -37.9 | 0.6 | 0.5 | -2.8 | -4.4 | -1.1 | -1.9 | -2.4 | -3.3 | -4.2 | -1.5 | -4.9 | 0.1 | 0.1 | 0.2 | 0.1 | |
| Net Income | -74.9 | -74.9 | -138.9 | -74.7 | -190.1 | -59.2 | -53.0 | -64.8 | -59.0 | -60.5 | -76.0 | -53.3 | -52.8 | -15.8 | -19.0 | -22.5 | -16.9 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 1.7 | 2.1 | 2.5 | 2.9 | 0.0 | 3.9 | 5.3 | 6.2 | 0.0 | 1.2 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 1.0 | 1.1 | 1.2 | ||
| Other Expense | -8.2 | -9.4 | 7.4 | 6.8 | -1.0 | 4.9 | 4.9 | 28.2 | 1.4 | 0.2 | ||
| IBT | -19.3 | -32.9 | -18.3 | -26.2 | -33.8 | -26.8 | -25.4 | -32.0 | -19.9 | -20.9 | ||
| Income Tax Expense | -35.9 | -1.2 | -0.6 | -0.2 | 0.3 | 0.1 | 0.0 | 0.1 | -0.2 | 0.1 | ||
| Net Income | 19.3 | -34.7 | -33.5 | -26.0 | -34.1 | -26.9 | -45.7 | -32.2 | -19.8 | -21.0 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.94 | $-2.43 | $-0.78 | $-0.74 | $-0.97 | $-1.49 | $-1.84 | $-2.62 | $-1.86 | $-1.90 | $-0.62 | $-0.86 | $-1.26 | $-0.89 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.94 | $-2.43 | $-0.78 | $-0.74 | $-0.97 | $-1.49 | $-1.84 | $-2.62 | $-1.86 | $-1.90 | $-0.62 | $-0.86 | $-1.26 | $-0.89 | |
| Shares Outstanding | 385.0 | 381.6 | 352.7 | 79.2 | 78.3 | 75.8 | 72.0 | 66.8 | 39.7 | 33.0 | 29.0 | 28.7 | 27.8 | 25.5 | 22.1 | 17.8 | 19.0 | |
| Diluted Shares Outstanding | 385.0 | 381.6 | 352.7 | 79.2 | 78.3 | 75.8 | 72.0 | 66.8 | 39.7 | 33.0 | 29.0 | 28.7 | 27.8 | 25.5 | 22.1 | 17.8 | 19.0 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.25 | $-0.27 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.25 | $-0.27 | ||
| Shares Outstanding | 385.0 | 382.6 | 380.5 | 378.2 | 374.5 | 371.5 | 372.3 | 294.1 | 79.7 | 79.2 | ||
| Diluted Shares Outstanding | 385.0 | 382.6 | 380.5 | 378.2 | 374.5 | 371.5 | 372.3 | 294.1 | 79.7 | 79.2 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 269.8 | 166.7 | 51.7 | 81.3 | 28.5 | 68.5 | 21.7 | 95.4 | 58.1 | 35.0 | 29.1 | 33.7 | 35.3 | 58.6 | 13.6 | 5.7 | |
| Short Term Investments | 124.9 | 126.1 | 63.2 | 84.5 | 0.0 | 0.0 | 37.0 | 0.0 | 5.1 | 24.4 | 65.9 | 81.6 | 49.1 | 21.4 | 39.9 | 0.0 | |
| Total Cash & ST Investments | 394.7 | 292.9 | 114.9 | 165.8 | 28.5 | 68.5 | 58.6 | 95.4 | 63.1 | 59.4 | 95.0 | 115.3 | 84.3 | 80.0 | 53.5 | 5.7 | |
| Accounts Receivable | 32.4 | 33.6 | 19.7 | 17.3 | 18.3 | 25.4 | 19.0 | 16.7 | 15.0 | 14.6 | 25.5 | 22.4 | 10.6 | 12.9 | 9.3 | 8.1 | |
| Inventory | 42.6 | 40.7 | 20.5 | 21.5 | 20.8 | 19.7 | 13.9 | 13.0 | 15.1 | 20.1 | 17.9 | 16.0 | 8.1 | 7.2 | 6.0 | 4.9 | |
| Other Current Assets | 10.3 | 8.7 | 3.1 | 4.3 | 4.5 | 4.0 | 4.6 | 2.1 | 1.5 | 2.5 | 5.7 | 2.2 | 1.5 | 1.1 | 1.3 | 2.2 | |
| Total Current Assets | 480.0 | 375.9 | 158.2 | 208.8 | 72.1 | 117.7 | 96.1 | 127.1 | 94.8 | 96.7 | 144.1 | 155.9 | 104.6 | 101.2 | 70.0 | 20.9 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 129.4 | 158.6 | 150.9 | 166.7 | 210.6 | 269.8 | 287.1 | 51.7 | 79.7 | 142.3 | |
| Short Term Investments | 65.5 | 78.5 | 107.2 | 126.1 | 155.7 | 124.9 | 175.2 | 63.2 | 49.2 | 0.0 | |
| Total Cash & ST Investments | 194.9 | 237.1 | 258.1 | 292.9 | 366.3 | 394.7 | 462.3 | 114.9 | 128.9 | 142.3 | |
| Accounts Receivable | 13.5 | 14.6 | 35.5 | 33.6 | 35.3 | 32.4 | 36.0 | 19.7 | 16.6 | 15.1 | |
| Inventory | 25.4 | 24.2 | 42.1 | 40.7 | 42.6 | 42.6 | 40.4 | 20.5 | 21.9 | 22.1 | |
| Other Current Assets | 238.6 | 230.2 | 8.4 | 8.7 | 9.3 | 10.3 | 8.9 | 3.1 | 3.4 | 3.6 | |
| Total Current Assets | 472.4 | 506.0 | 344.0 | 375.9 | 453.6 | 480.0 | 547.6 | 158.2 | 170.7 | 183.1 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 74.1 | 71.4 | 54.9 | 59.5 | 65.2 | 55.6 | 12.9 | 8.8 | 12.3 | 16.5 | 15.3 | 13.9 | 6.8 | 5.0 | 3.3 | 2.3 | |
| Goodwill | 106.3 | 111.3 | 106.3 | 106.3 | 106.4 | 106.6 | 104.1 | 104.1 | 104.1 | 104.1 | 104.1 | 104.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 24.1 | 29.0 | 1.4 | 12.6 | 27.9 | 40.2 | 46.2 | 57.4 | 68.6 | 79.8 | 91.0 | 102.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.5 | 27.5 | 1.9 | 3.7 | 2.8 | 1.3 | |
| Other Long-Term Assets | 19.2 | 24.8 | 2.3 | 3.1 | 3.7 | 4.7 | 5.5 | 6.2 | 7.5 | 9.3 | 10.1 | 4.0 | 3.6 | 3.9 | 3.2 | 0.3 | |
| Total Long-Term Assets | 228.7 | 236.5 | 164.9 | 181.5 | 203.1 | 207.1 | 168.7 | 176.5 | 192.6 | 209.7 | 227.0 | 251.7 | 12.3 | 12.5 | 9.3 | 3.9 | |
| Total Assets | 708.7 | 612.3 | 323.1 | 390.3 | 275.2 | 324.8 | 264.8 | 303.6 | 287.4 | 306.4 | 371.1 | 407.6 | 116.9 | 113.7 | 79.3 | 24.8 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 44.2 | 47.2 | 71.0 | 71.4 | 72.2 | 74.1 | 77.8 | 54.9 | 55.7 | 56.7 | |
| Goodwill | 0.0 | 0.0 | 111.7 | 111.3 | 106.3 | 106.3 | 106.3 | 106.3 | 106.2 | 106.3 | |
| Intangible Assets | 0.0 | 0.0 | 28.1 | 29.0 | 23.4 | 24.1 | 24.8 | 1.4 | 4.2 | 7.2 | |
| Long-Term Investments | 22.1 | 0.0 | 0.0 | 0.0 | 0.0 | 5.0 | 5.7 | 0.8 | 0.8 | 0.8 | |
| Other Long-Term Assets | 0.9 | 3.7 | 24.8 | 24.8 | 26.0 | 19.2 | 15.6 | 1.5 | 2.4 | 2.5 | |
| Total Long-Term Assets | 67.2 | 50.9 | 235.6 | 236.5 | 227.9 | 228.7 | 230.1 | 164.9 | 168.5 | 172.8 | |
| Total Assets | 539.6 | 557.0 | 579.6 | 612.3 | 681.5 | 708.7 | 777.7 | 323.1 | 339.3 | 355.8 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 12.6 | 12.3 | 9.2 | 7.9 | 10.6 | 9.2 | 6.5 | 4.0 | 4.2 | 4.0 | 6.1 | 5.9 | 4.4 | 2.6 | 4.0 | 3.2 | |
| Short-Term Debt | 60.6 | 6.2 | 68.2 | 5.8 | 9.9 | 3.0 | 1.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.7 | 0.0 | 8.9 | 7.7 | |
| Other Current Liabilities | 31.9 | 27.2 | 19.3 | 15.3 | 13.6 | 28.6 | 12.7 | 22.1 | 19.0 | 16.4 | 14.6 | 16.5 | 10.9 | 7.2 | 5.2 | 6.3 | |
| Current Liabilities | 123.8 | 65.9 | 109.3 | 43.4 | 49.6 | 54.2 | 32.8 | 37.6 | 33.5 | 29.5 | 30.1 | 29.4 | 17.2 | 11.6 | 20.2 | 18.5 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6.6 | 7.3 | 11.8 | 12.3 | 10.9 | 12.6 | 13.1 | 9.2 | 7.3 | 6.1 | |
| Short-Term Debt | 5.1 | 5.1 | 6.3 | 6.2 | 61.0 | 60.6 | 60.5 | 68.2 | 13.0 | 12.4 | |
| Other Current Liabilities | 53.0 | 41.3 | 20.8 | 27.2 | 35.2 | 30.9 | 27.7 | 19.1 | 18.3 | 11.8 | |
| Current Liabilities | 108.0 | 98.0 | 56.2 | 65.9 | 120.6 | 123.8 | 121.6 | 109.3 | 51.8 | 46.8 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.3 | 26.8 | 34.4 | 96.9 | 101.8 | 92.4 | 58.1 | 172.1 | 195.2 | 195.0 | 195.7 | 195.5 | 0.0 | 0.0 | 1.2 | 10.1 | |
| Capital Leases | 29.6 | 32.7 | 34.7 | 37.8 | 40.6 | 41.2 | 6.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.8 | 1.1 | 0.8 | 1.1 | 4.3 | 8.7 | 11.5 | 13.7 | 16.9 | 21.1 | 23.6 | 26.2 | 0.0 | 0.0 | 0.0 | 184.6 | |
| Total Liabilities | 198.5 | 140.6 | 159.9 | 471.8 | 180.6 | 185.7 | 111.2 | 231.5 | 256.4 | 253.2 | 256.2 | 257.1 | 19.8 | 13.1 | 22.4 | 214.0 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 22.3 | 23.5 | 25.2 | 26.8 | 28.4 | 29.9 | 31.4 | 34.4 | 90.7 | 92.9 | |
| Capital Leases | 0.0 | 28.3 | 31.2 | 32.7 | 34.3 | 29.6 | 31.1 | 30.4 | 35.1 | 36.1 | |
| Def. Tax Liability | 1.1 | 1.1 | 1.0 | 1.1 | 0.8 | 0.8 | 0.8 | 0.8 | 1.0 | 1.0 | |
| Total Liabilities | 140.0 | 132.4 | 125.0 | 140.6 | 192.2 | 198.5 | 200.4 | 159.9 | 471.0 | 469.2 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.4 | 0.4 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,124.6 | -1,185.7 | -1,000.8 | -926.1 | -736.0 | -676.8 | -623.6 | -558.9 | -500.2 | -439.5 | -363.5 | -310.2 | -257.3 | -240.8 | -221.8 | -199.3 | |
| Comprehensive Income | -1.5 | 1.2 | -2.2 | -1.9 | -0.9 | 0.1 | -0.6 | -0.7 | -0.6 | -0.8 | -1.1 | -0.8 | -0.7 | -0.8 | -0.8 | -0.8 | |
| Total Common Equity | 510.3 | 471.7 | 163.2 | -81.5 | 94.6 | 139.1 | 153.6 | 72.1 | 30.9 | 53.2 | 114.9 | 150.4 | 97.1 | 100.7 | 56.9 | -189.2 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -1,279.8 | -1,245.1 | -1,211.7 | -1,185.7 | -1,151.6 | -1,124.6 | -1,078.9 | -1,000.8 | -981.0 | -960.0 | |
| Comprehensive Income | -0.5 | -1.9 | 1.2 | 1.2 | -1.4 | -1.5 | -1.8 | -2.2 | -1.9 | -1.6 | |
| Total Common Equity | 399.7 | 424.5 | 454.6 | 471.7 | 489.3 | 510.3 | 577.3 | 163.2 | -131.7 | -113.4 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 90.6 | 33.0 | 98.2 | 102.7 | 111.6 | 95.4 | 60.0 | 172.1 | 195.2 | 195.0 | 195.7 | 195.5 | 0.0 | 0.0 | 10.1 | 17.8 | |
| Book Value | 510.3 | 471.7 | 163.2 | -81.5 | 94.6 | 139.1 | 153.6 | 72.1 | 30.9 | 53.2 | 114.9 | 150.4 | 97.1 | 100.7 | 56.9 | -189.2 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 399.7 | 424.5 | 454.6 | 471.7 | 489.3 | 510.3 | 577.3 | 163.2 | -131.7 | -113.4 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -118.6 | -74.9 | -138.9 | -74.7 | -190.1 | -59.2 | -53.0 | -64.8 | -59.0 | -60.5 | -76.0 | -53.3 | -52.8 | -15.8 | -19.0 | -22.5 | -16.9 | |
| Depreciation & Amortization | 16.9 | 1.7 | 16.9 | 15.2 | 15.0 | 15.6 | 15.9 | 15.8 | 16.6 | 18.6 | 17.9 | 16.1 | 4.1 | 2.6 | 1.5 | 1.1 | 1.5 | |
| Stock-Based Compensation | 25.2 | 29.6 | 31.7 | 13.1 | 14.9 | 16.1 | 14.5 | 11.4 | 11.0 | 9.1 | 13.9 | 16.8 | 20.9 | 6.4 | 4.1 | 2.8 | 1.6 | |
| Change Working Capital | -26.4 | -45.0 | -12.1 | 1.8 | -15.5 | -19.9 | 2.4 | -13.2 | -2.5 | 9.2 | 4.8 | -8.2 | -7.8 | 6.7 | -4.1 | -1.0 | 1.9 | |
| Change In Accounts Receivable | -0.2 | -1.4 | 9.0 | -3.0 | 1.1 | 6.7 | -7.6 | -2.1 | -1.8 | -0.6 | 10.5 | -2.8 | -3.4 | 2.4 | -3.7 | -1.2 | 0.2 | |
| Change In Accounts Payable | -7.3 | 2.4 | 0.0 | 1.6 | -2.8 | 1.3 | 3.4 | 2.1 | -0.3 | 0.6 | -2.3 | 0.8 | 0.1 | 1.8 | -1.8 | 0.5 | 0.9 | |
| Change In Inventories | -15.8 | -11.5 | -9.9 | -4.9 | -8.5 | -4.8 | -8.6 | -2.7 | 1.5 | 4.6 | -3.4 | -3.7 | -6.2 | -1.5 | -1.7 | -1.1 | -1.0 | |
| Other Non-cash Items | 45.0 | 14.2 | -41.1 | 1.3 | 86.3 | 3.4 | 4.6 | 3.1 | 8.6 | -0.5 | 0.3 | -3.8 | 13.4 | 0.3 | 0.1 | -21.3 | 0.4 | |
| Cash from Operations | -127.0 | 0.0 | 0.0 | -43.3 | -89.4 | -44.1 | -15.4 | -35.2 | -25.2 | -24.1 | -39.1 | -34.7 | -22.6 | -1.6 | -17.5 | -17.5 | -11.5 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 19.3 | -34.7 | -33.5 | -26.0 | -34.1 | -26.9 | -45.7 | -32.2 | -19.8 | -21.0 | |
| Depreciation & Amortization | 0.0 | 5.6 | 4.0 | 4.2 | 4.0 | 3.9 | 3.9 | 5.2 | 3.9 | 4.0 | |
| Stock-Based Compensation | 5.7 | 7.5 | 5.4 | 9.0 | 7.5 | 5.9 | 6.7 | 3.6 | 3.5 | 3.4 | |
| Change Working Capital | -30.9 | -1.2 | 0.0 | -15.6 | 8.7 | -10.7 | -4.0 | -10.5 | -1.6 | 1.7 | |
| Change In Accounts Receivable | 6.7 | -5.8 | 2.0 | -2.0 | 6.7 | -2.7 | 4.3 | 0.7 | -3.7 | -1.6 | |
| Change In Accounts Payable | 0.7 | 0.0 | 0.0 | -0.6 | 0.0 | -2.2 | -0.4 | 0.0 | 2.1 | 1.3 | |
| Change In Inventories | -1.2 | -1.8 | 3.8 | -3.8 | 5.0 | -2.1 | -6.4 | -6.3 | -1.7 | -1.3 | |
| Other Non-cash Items | 4.7 | 0.5 | 3.5 | -1.8 | -0.1 | 0.0 | 0.1 | -28.6 | 14.5 | 0.1 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -14.1 | -11.4 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -3.7 | -8.3 | -8.4 | -2.8 | -3.8 | -13.3 | -12.7 | -2.5 | -0.4 | -1.6 | -5.1 | -10.7 | -7.4 | -4.7 | -2.4 | -1.7 | -1.5 | |
| Acquisitions | 573.1 | 0.0 | 278.6 | 0.0 | 0.0 | 0.0 | -5.2 | 0.0 | 0.0 | 0.1 | 2.3 | -2.3 | -112.9 | 3.1 | -14.0 | 0.0 | 0.0 | |
| Investments | -236.0 | -140.9 | 0.0 | -94.9 | -137.3 | 0.0 | 0.0 | -62.4 | -1.5 | -6.3 | -38.6 | -67.0 | -132.6 | -59.4 | -35.4 | -71.4 | 0.0 | |
| Sales of Investment | 265.0 | 179.0 | 0.0 | 118.0 | 53.0 | 0.0 | 36.8 | 25.6 | 6.5 | 25.6 | 86.4 | 103.4 | 74.5 | 33.4 | 51.8 | 30.0 | 0.0 | |
| Other Investing Activities | 270.2 | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 21.0 | 0.0 | 0.0 | -0.1 | 0.0 | 2.3 | 0.0 | 0.0 | 14.0 | -2.0 | 0.2 | |
| Cash from Investing | 305.3 | 0.0 | 0.0 | 20.2 | -88.1 | -11.9 | 40.0 | -39.3 | 4.7 | 17.7 | 45.1 | 25.7 | -178.4 | -27.6 | 14.0 | -45.1 | -1.3 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.5 | -0.9 | -1.9 | -5.1 | -3.4 | -2.3 | -1.9 | -0.8 | -0.1 | -0.9 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | -1.4 | 0.0 | 0.0 | 280.0 | 13.0 | 0.0 | |
| Investments | -30.2 | 0.0 | 0.0 | -32.3 | 0.0 | -78.6 | -74.8 | 0.0 | -39.0 | -49.0 | |
| Sales of Investment | 25.0 | 0.0 | 0.0 | 52.0 | 0.0 | 50.0 | 127.0 | 0.0 | 26.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -13.0 | -49.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -13.1 | -49.9 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -10.8 | 0.0 | 0.0 | -2.1 | -6.8 | -0.5 | 0.0 | -51.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -12.1 | -12.9 | 0.0 | |
| Debt Issued | 0.0 | 33.0 | -65.2 | -2.4 | -2.2 | 16.8 | 35.4 | -60.3 | -23.2 | 0.3 | -0.7 | 0.2 | 195.5 | 0.0 | 1.9 | 5.2 | 17.8 | |
| Issuance of Common Stock | 2.0 | 0.0 | 0.0 | 0.0 | 225.0 | 0.0 | 20.2 | 0.0 | 59.5 | 29.0 | 0.1 | 0.0 | 78.2 | 0.0 | 56.0 | 76.9 | 7.4 | |
| Repurchase of Common Stock | -41.1 | 0.0 | -40.9 | -5.4 | -0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -0.3 | 0.0 | 0.0 | 0.8 | 13.2 | 16.5 | 0.6 | 54.6 | -1.8 | 0.0 | 0.0 | 5.3 | 122.1 | 5.8 | 4.6 | 6.3 | -3.6 | |
| Cash from Financing | -50.3 | 0.0 | 0.0 | -6.8 | 230.8 | 16.0 | 20.9 | 2.8 | 57.7 | 29.0 | 0.1 | 5.3 | 200.3 | 5.8 | 48.5 | 70.4 | 3.8 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.3 | -0.8 | |
| Debt Issued | 27.4 | -1.2 | -2.9 | -1.5 | -56.5 | -1.1 | -1.3 | -6.3 | -0.3 | -0.8 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | -0.1 | -0.2 | 0.0 | 0.0 | 0.0 | -29.4 | -11.1 | -0.2 | -0.4 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.1 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.0 | -1.2 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 127.5 | -48.2 | 116.3 | -29.8 | 52.9 | -40.1 | 45.8 | -71.7 | 37.3 | 23.0 | 5.9 | -4.6 | -1.5 | -23.4 | 45.1 | 7.8 | -8.9 | |
| Closing Cash Balance | 269.8 | 120.6 | 168.8 | 52.5 | 82.3 | 29.5 | 69.5 | 23.7 | 95.4 | 58.1 | 35.0 | 29.1 | 33.7 | 35.3 | 58.6 | 13.6 | 5.7 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -11.4 | -29.2 | 7.7 | -15.3 | -43.1 | -59.2 | -17.2 | 235.8 | -28.0 | -62.6 | |
| Closing Cash Balance | 120.6 | 132.0 | 161.2 | 153.5 | 168.8 | 211.9 | 271.1 | 288.3 | 51.7 | 80.5 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -130.7 | -82.7 | -151.8 | -46.1 | -93.2 | -57.3 | -28.1 | -37.7 | -25.6 | -25.7 | -44.2 | -45.3 | -30.0 | -6.3 | -19.9 | -19.2 | -13.0 | |
| Real Free Cash Flow | -155.9 | -112.3 | -183.5 | -59.2 | -108.1 | -73.4 | -42.6 | -49.1 | -36.6 | -34.8 | -58.0 | -62.2 | -51.0 | -12.7 | -24.0 | -22.0 | -14.6 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.7 | -23.1 | -22.6 | -35.3 | -17.4 | -30.1 | -41.0 | -63.3 | -14.1 | -12.3 | |
| Real Free Cash Flow | -7.4 | -30.6 | -27.9 | -44.3 | -24.9 | -36.0 | -47.7 | -66.8 | -17.6 | -15.7 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -5 | -4.3 | 179.3 |
| P/S | 4.4 | 2.6 | 390.6 |
| P/B | 0.9 | 1.8 | 113.4 |
| P/FCF | -3.4 | -5.4 | 149.9 |
| Market cap | $0.4 | $0.4 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 5.1 % | 32 % | 0 % |
| Debt to Income | -36.6 % | -164.9 % | 0 % |
| Debt to Free cash flow | -24.8 % | -106.2 % | 0 % |
| Interest expense percentage | -0 % | -8.9 % | 11.2 % |
| Current ratio | 4.4 | 3.8 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -18.7 % | -24.6 % | 0 % |
| ROA | -13.9 % | -22.2 % | 0 % |
| CapEx to Revenue | 8.7 % | 5 % | 6 % |
| RaD to Revenue | 0 % | 31.7 % | 0 % |
| ROEM | 104,316.6 | 166454.2 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 47.9 % | 57.4 % | 61.9 % |
| Operating margin | -89.2 % | -55.1 % | 17.9 % |
| Net margin | -99.6 % | -62.2 % | 13 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 382.6 mil | 74.7 mil |
| Employee count | 0.8 tis | 0.5 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
